Aurevia is pleased to announce a new partnership with RAPS, the Regulatory Affairs Professionals Society, to strengthen the medtech programme at Labquality Days, taking place on 11–12 February 2027 in Helsinki, Finland.
Labquality Days has brought professionals together for 50 years, and for the past seven years it has included a dedicated programme for the medtech community. Aurevia, formerly part of Labquality until 2026, has played a key role in developing this programme and is now pleased to continue this work together with RAPS.
Image: Brian Savoie, Sr. Vice President, Education & International Programs at RAPS (left), and Mika Siitonen, Operations Manager at Aurevia and Medtech Program Lead at Labquality Days.
The Medtech Compliance Forum by Aurevia & RAPS will be a dedicated part of Labquality Days for professionals across the medtech field. The forum will focus on compliance, regulatory strategy, evidence requirements, and practical challenges throughout the product lifecycle in a rapidly evolving field.
Aurevia will contribute its expertise in quality assurance, regulatory affairs, and clinical research, while RAPS will bring its global network and regulatory expertise. Together, the organisations will add an international perspective and strong practical relevance to one of the Nordic region’s leading events for medical device industry, quality, and regulatory professionals.
This partnership also builds on a shared milestone: Labquality Days has reached its 50-year mark this year, while RAPS is also currently celebrating its 50th anniversary. We look forward to carrying this legacy forward together in 2027 by connecting people, sharing expertise, and supporting progress across the global healthtech and medtech community.
We warmly welcome medtech and healthtech professionals, medical device manufacturers, regulatory experts, quality leaders, and innovators to join us in 2027 and help shape the future of health technology.
Share this article
